ArticleCytometry. Part A : the journal of the International Society for Analytical Cytology2020
Handling and Processing of Blood Specimens from Patients with COVID-19 for Safe Studies on Cell Phenotype and Cytokine Storm.
Article in Cytometry. Part A : the journal of the International Society for Analytical Cytology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 33 citations in OpenAlex.
- Syndromic surveillance and immunoprofiling of inbound travelers as a proxy for national SARS-CoV-2 trends in Uganda: implications for border health policy in resource-limited settings.BMC infectious diseases · 2026Article
- Influenza A (H1N1) and COVID-19 Pneumonias: An Evaluation in the Light of New Hematologic Indices.Journal of inflammation research · 2025Article
- Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients.Nature communications · 2024Article
- Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia.Communications biology · 2022Article
- Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival.Frontiers in immunology · 2022Article
- Mobile technology: A tool for healthcare and a boon in pandemic.Journal of family medicine and primary care · 2022Review
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition).European journal of immunology · 2021Review
- The role of inflammatory indices in the outcome of COVID-19 cancer patients.Medical oncology (Northwood, London, England) · 2021Article
- Single-cell systems biology, COVID-19, and vaccination.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021Article
- Biospecimen Collection During the COVID-19 Pandemic.American journal of clinical pathology · 2021Review
- Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.Frontiers in immunology · 2021Article
- A Cytometrist's Guide to Coordinating and Performing Effective COVID-19 Research.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021Review
- Modifying Regulatory Practices to Create a Safe and Effective Working Environment Within a Shared Resource Laboratory During a Global Pandemic.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2021Review
- [Management of samples in pathology laboratories and biobanks during the Covid-19 pandemic].Revue francophone des laboratoires : RFL · 2021Article
- The Role of Different Inflammatory Indices in the Diagnosis of COVID-19.International journal of general medicine · 2021Article
- Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia.EMBO molecular medicine · 2020Article
- Safety considerations during return to work in the context of stable COVID-19 epidemic control: an analysis of health screening results of all returned staff from a hospital.Epidemiology and infection · 2020Article
- A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.Medical science monitor : international medical journal of experimental and clinical research · 2020Article
- Safety considerations in the bioanalytical laboratories handling specimens from coronavirus disease 2019 patients.Bioanalysis · 2020Article
- Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia.Nature communications · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The pandemic caused by severe acute respiratory syndrome coronavirus 2 heavily involves all those working in a laboratory. Samples from known infected patients or donors who are considered healthy can arrive, and a colleague might be asymptomatic but able to transmit the virus. Working in a clinical laboratory is posing several safety challenges. Few years ago, International Society for Advancement of Cytometry published guidelines to safely analyze and sort human samples that were revised in these days. We describe the procedures that we have been following since the first patient appeared in Italy, which have only slightly modified our standard one, being all human samples associated with risks. © 2020 International Society for Advancement of Cytometry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.